Suivant

Lecture automatique

Dr. Kudchadkar on the FDA Approval of Avelumab in Merkel Cell Carcinoma

0 Vues • 07/17/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

Ragini Kudchadkar, MD, assistant professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, discusses the FDA approval of avelumab for the treatment of patients with Merkel cell carcinoma.

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique